Who is sponsoring NCT07181824?

NCT07181824 is sponsored by Centre Hospitalier Sud Francilien.

What drugs are being tested in NCT07181824?

Interventions in NCT07181824: Diagnostic tedst.

What condition does NCT07181824 study?

NCT07181824 studies Pneumonia Ventilator Associated.

Is NCT07181824 still recruiting?

NCT07181824 is currently recruiting now. Last updated 9 December 2025.

Last reviewed 2025-12-09 · How we verify

NCT07181824: PAVM-RéaCHSF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024

Recruiting now Last updated 9 December 2025

What this trial tests

trial testing Diagnostic tedst in Pneumonia Ventilator Associated in 100 participants. Currently enrolling.

Timeline

25 August 2025

Primary endpoint
30 June 2026

30 June 2026

Quick facts

Lead sponsor	Centre Hospitalier Sud Francilien
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	25 August 2025
Primary completion	30 June 2026
Estimated completion	30 June 2026
Sites	1 location across France

Drugs / interventions tested

Diagnostic tedst

Conditions studied

Pneumonia Ventilator Associated — all drugs for Pneumonia Ventilator Associated →

Sponsor

Centre Hospitalier Sud Francilien

Who can join

18 and older, any sex, with Pneumonia Ventilator Associated. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to to analyze respiratory samples performed in mechanically ventilated ICU patients and to assess whether the SRLF criteria for defining VAP were respected among patients admited to the Intensive care medicine at a regional hospital en France

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier Sud Francilien trials

Trials by the same sponsor.

NCT07495709 — Reactions to Oro-facial Solicitations : a Predictor of Eating Difficulties for Premature Babies of 36 Weeks Gestation Ad · not yet recruiting
NCT07430293 — Hybrid Closed-Loop Insulin Delivery After Pancreatectomy · NA · not yet recruiting
NCT07414186 — Study of Pre Hospital Management of Polytrauma Patients by Medical Teams From a Department in the Parisian Region · not yet recruiting
NCT07144059 — Impact of Non-medicalized ECG Practices Initiated by SAMU in Dispatch Strategies · not yet recruiting
NCT07329192 — Study on How Parents' Anticipated Choice of a Doctor at the Maternity Hospital Influences the Newborn's First Post-disch · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07181824 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Sud Francilien
Last refreshed: 9 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07181824.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing